Please login to the form below

Not currently logged in
Email:
Password:

UCLA’s Eugene Washington joins J&J board

Health policy specialist is also chair of government body to develop comparative effectiveness research programme

J&J, Eugene WashingtonJohnson & Johnson (J&J) has appointed health policy specialist Dr Eugene Washington of the University of California, Los Angeles (UCLA) to the company's board of directors.

Washington is currently vice chancellor of health sciences and dean of the David Geffen School of Medicine at UCLA, as well as chair of the board of governors of the Patient-Centered Outcomes Research Institute (PCROI).

The Institute is a national research organisation authorised by Barack Obama's Patient Protection and Affordable Care Act to develop a comparative effectiveness research programme, which can be used to inform health policy through evidence-based research.

"Gene has dedicated his life to improving healthcare as a practitioner, researcher, teacher, administrator and policy advisor,” said Bill Weldon, chair of J&J.

“He brings our board valuable leadership and insight into analysing healthcare policy, assessing medical technologies and sharing forward-looking perspectives on the role we can play in addressing the world's healthcare challenges."

Washington joined UCLA in 2010 having previously held the position of executive vice chancellor, provost and professor of gynaecology, epidemiology and health policy at the University of California San Francisco (UCSF).

The other positions he currently holds include serving as a member of the board of directors of the California Wellness Foundation.

13th November 2012

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics